APO Research
Talk to an analyst

APO RESEARCH · REPORT

Factor IX Complex Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Factor IX Complex Drug Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchFactor IX Complex Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Factor IX Complex Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Factor IX Complex Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Factor IX Complex Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Factor IX Complex Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Factor IX Complex Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Factor IX Complex Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Factor IX Complex Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Factor IX Complex Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Factor IX Complex Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Factor IX Complex Drug include Takeda, Grifols, Prothya Biosolutions, Octapharma and CSL Behring, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Factor IX Complex Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Factor IX Complex Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Factor IX Complex Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Factor IX Complex Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Factor IX Complex Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Factor IX Complex Drug sales, projected growth trends, production technology, application and end-user industry.

Factor IX Complex Drug Segment by Company

Takeda

Grifols

Prothya Biosolutions

Octapharma

CSL Behring

Factor IX Complex Drug Segment by Type

Prothromplex

Profilnine

Octaplex

Cofact

Beriplex

Other

Factor IX Complex Drug Segment by Application

Hemophilia B

Acquired Coagulation Factor Deficiency

Factor IX Complex Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor IX Complex Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Factor IX Complex Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor IX Complex Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Factor IX Complex Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Factor IX Complex Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Factor IX Complex Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Factor IX Complex Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prothromplex Major Manufacturers Table 3. Profilnine Major Manufacturers Table 4. Octaplex Major Manufacturers Table 5. Cofact Major Manufacturers Table 6. Beriplex Major Manufacturers Table 7. Other Major Manufacturers Table 8. Global Factor IX Complex Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hemophilia B Major Manufacturers Table 10. Acquired Coagulation Factor Deficiency Major Manufacturers Table 11. Factor IX Complex Drug Industry Trends Table 12. Factor IX Complex Drug Industry Drivers Table 13. Factor IX Complex Drug Industry Opportunities and Challenges Table 14. Factor IX Complex Drug Industry Restraints Table 15. Global Factor IX Complex Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Factor IX Complex Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Factor IX Complex Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Factor IX Complex Drug Revenue Market Share by Region (2021-2026) Table 19. Global Factor IX Complex Drug Revenue Market Share by Region (2027-2032) Table 20. Global Factor IX Complex Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Factor IX Complex Drug Sales by Region (2021-2026) & (k units) Table 22. Global Factor IX Complex Drug Sales by Region (2027-2032) & (k units) Table 23. Global Factor IX Complex Drug Sales Market Share by Region (2021-2026) Table 24. Global Factor IX Complex Drug Sales Market Share by Region (2027-2032) Table 25. Global Factor IX Complex Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Factor IX Complex Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Factor IX Complex Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Factor IX Complex Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Factor IX Complex Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Factor IX Complex Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Factor IX Complex Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Factor IX Complex Drug Manufacturers, Product Type & Application Table 33. Global Factor IX Complex Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Factor IX Complex Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Factor IX Complex Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Factor IX Complex Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Factor IX Complex Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Factor IX Complex Drug Revenue Market Share by Type (2021-2026) Table 40. Global Factor IX Complex Drug Revenue Market Share by Type (2027-2032) Table 41. Global Factor IX Complex Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 43. Global Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 44. Global Factor IX Complex Drug Sales Market Share by Type (2021-2026) Table 45. Global Factor IX Complex Drug Sales Market Share by Type (2027-2032) Table 46. Global Factor IX Complex Drug Price by Type (2021-2026) & (US$/unit) Table 47. Global Factor IX Complex Drug Price by Type (2027-2032) & (US$/unit) Table 48. Global Factor IX Complex Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Factor IX Complex Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Factor IX Complex Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Factor IX Complex Drug Revenue Market Share by Application (2021-2026) Table 52. Global Factor IX Complex Drug Revenue Market Share by Application (2027-2032) Table 53. Global Factor IX Complex Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 55. Global Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 56. Global Factor IX Complex Drug Sales Market Share by Application (2021-2026) Table 57. Global Factor IX Complex Drug Sales Market Share by Application (2027-2032) Table 58. Global Factor IX Complex Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Factor IX Complex Drug Price by Application (2027-2032) & (US$/unit) Table 60. Takeda Company Information Table 61. Takeda Business Overview Table 62. Takeda Factor IX Complex Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Takeda Factor IX Complex Drug Product Portfolio Table 64. Takeda Recent Development Table 65. Grifols Company Information Table 66. Grifols Business Overview Table 67. Grifols Factor IX Complex Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Grifols Factor IX Complex Drug Product Portfolio Table 69. Grifols Recent Development Table 70. Prothya Biosolutions Company Information Table 71. Prothya Biosolutions Business Overview Table 72. Prothya Biosolutions Factor IX Complex Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Prothya Biosolutions Factor IX Complex Drug Product Portfolio Table 74. Prothya Biosolutions Recent Development Table 75. Octapharma Company Information Table 76. Octapharma Business Overview Table 77. Octapharma Factor IX Complex Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Octapharma Factor IX Complex Drug Product Portfolio Table 79. Octapharma Recent Development Table 80. CSL Behring Company Information Table 81. CSL Behring Business Overview Table 82. CSL Behring Factor IX Complex Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. CSL Behring Factor IX Complex Drug Product Portfolio Table 84. CSL Behring Recent Development Table 85. North America Factor IX Complex Drug Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Factor IX Complex Drug Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 88. North America Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 89. North America Factor IX Complex Drug Sales Price by Type (2021-2026) & (US$/unit) Table 90. North America Factor IX Complex Drug Sales Price by Type (2027-2032) & (US$/unit) Table 91. North America Factor IX Complex Drug Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Factor IX Complex Drug Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 94. North America Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 95. North America Factor IX Complex Drug Sales Price by Application (2021-2026) & (US$/unit) Table 96. North America Factor IX Complex Drug Sales Price by Application (2027-2032) & (US$/unit) Table 97. North America Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Factor IX Complex Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. North America Factor IX Complex Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. North America Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 101. North America Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 102. North America Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 103. North America Factor IX Complex Drug Sales Price by Country (2021-2026) & (US$/unit) Table 104. North America Factor IX Complex Drug Sales Price by Country (2027-2032) & (US$/unit) Table 105. United States Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 106. Canada Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 107. Mexico Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 108. Europe Factor IX Complex Drug Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Factor IX Complex Drug Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 111. Europe Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 112. Europe Factor IX Complex Drug Sales Price by Type (2021-2026) & (US$/unit) Table 113. Europe Factor IX Complex Drug Sales Price by Type (2027-2032) & (US$/unit) Table 114. Europe Factor IX Complex Drug Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Factor IX Complex Drug Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 117. Europe Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 118. Europe Factor IX Complex Drug Sales Price by Application (2021-2026) & (US$/unit) Table 119. Europe Factor IX Complex Drug Sales Price by Application (2027-2032) & (US$/unit) Table 120. Europe Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Factor IX Complex Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. Europe Factor IX Complex Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. Europe Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 124. Europe Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 125. Europe Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 126. Europe Factor IX Complex Drug Sales Price by Country (2021-2026) & (US$/unit) Table 127. Europe Factor IX Complex Drug Sales Price by Country (2027-2032) & (US$/unit) Table 128. Germany Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 129. France Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 130. U.K. Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 131. Italy Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 132. Russia Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 133. Spain Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 135. Switzerland Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 136. Sweden Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 137. Poland Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 138. China Factor IX Complex Drug Revenue by Type (2021-2026) & (US$ Million) Table 139. China Factor IX Complex Drug Revenue by Type (2027-2032) & (US$ Million) Table 140. China Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 141. China Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 142. China Factor IX Complex Drug Sales Price by Type (2021-2026) & (US$/unit) Table 143. China Factor IX Complex Drug Sales Price by Type (2027-2032) & (US$/unit) Table 144. China Factor IX Complex Drug Revenue by Application (2021-2026) & (US$ Million) Table 145. China Factor IX Complex Drug Revenue by Application (2027-2032) & (US$ Million) Table 146. China Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 147. China Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 148. China Factor IX Complex Drug Sales Price by Application (2021-2026) & (US$/unit) Table 149. China Factor IX Complex Drug Sales Price by Application (2027-2032) & (US$/unit) Table 150. Asia Factor IX Complex Drug Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Factor IX Complex Drug Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 153. Asia Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 154. Asia Factor IX Complex Drug Sales Price by Type (2021-2026) & (US$/unit) Table 155. Asia Factor IX Complex Drug Sales Price by Type (2027-2032) & (US$/unit) Table 156. Asia Factor IX Complex Drug Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Factor IX Complex Drug Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 159. Asia Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 160. Asia Factor IX Complex Drug Sales Price by Application (2021-2026) & (US$/unit) Table 161. Asia Factor IX Complex Drug Sales Price by Application (2027-2032) & (US$/unit) Table 162. Asia Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Factor IX Complex Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Asia Factor IX Complex Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Asia Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 166. Asia Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 167. Asia Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 168. Asia Factor IX Complex Drug Sales Price by Country (2021-2026) & (US$/unit) Table 169. Asia Factor IX Complex Drug Sales Price by Country (2027-2032) & (US$/unit) Table 170. Japan Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 171. South Korea Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 172. India Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 173. Australia Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 174. Taiwan Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 175. Southeast Asia Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 176. SAMEA Factor IX Complex Drug Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Factor IX Complex Drug Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 179. SAMEA Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 180. SAMEA Factor IX Complex Drug Sales Price by Type (2021-2026) & (US$/unit) Table 181. SAMEA Factor IX Complex Drug Sales Price by Type (2027-2032) & (US$/unit) Table 182. SAMEA Factor IX Complex Drug Revenue by Application (2021-2026) & (US$ Million) Table 183. SAMEA Factor IX Complex Drug Revenue by Application (2027-2032) & (US$ Million) Table 184. SAMEA Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 185. SAMEA Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 186. SAMEA Factor IX Complex Drug Sales Price by Application (2021-2026) & (US$/unit) Table 187. SAMEA Factor IX Complex Drug Sales Price by Application (2027-2032) & (US$/unit) Table 188. SAMEA Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. SAMEA Factor IX Complex Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. SAMEA Factor IX Complex Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. SAMEA Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 192. SAMEA Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 193. SAMEA Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 194. SAMEA Factor IX Complex Drug Sales Price by Country (2021-2026) & (US$/unit) Table 195. SAMEA Factor IX Complex Drug Sales Price by Country (2027-2032) & (US$/unit) Table 196. Brazil Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 197. Argentina Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 198. Chile Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 199. Colombia Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 200. Peru Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 201. Saudi Arabia Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 202. Israel Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 203. UAE Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 204. Turkey Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 205. Iran Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 206. Egypt Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Factor IX Complex Drug Distributors List Table 210. Factor IX Complex Drug Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Factor IX Complex Drug Image Figure 2. Global Factor IX Complex Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Factor IX Complex Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prothromplex Image Figure 5. Profilnine Image Figure 6. Octaplex Image Figure 7. Cofact Image Figure 8. Beriplex Image Figure 9. Other Image Figure 10. Global Factor IX Complex Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Factor IX Complex Drug Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hemophilia B Image Figure 13. Acquired Coagulation Factor Deficiency Image Figure 14. Global Factor IX Complex Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Factor IX Complex Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Factor IX Complex Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Factor IX Complex Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Factor IX Complex Drug Sales (2021-2032) & (k units) Figure 20. Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Factor IX Complex Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Factor IX Complex Drug Sales YoY (2021-2032) & (k units) Figure 23. Europe Factor IX Complex Drug Sales YoY (2021-2032) & (k units) Figure 24. China Factor IX Complex Drug Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Factor IX Complex Drug Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Factor IX Complex Drug Sales YoY (2021-2032) & (k units) Figure 27. Global Factor IX Complex Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Factor IX Complex Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Factor IX Complex Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Factor IX Complex Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Factor IX Complex Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Factor IX Complex Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Factor IX Complex Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Factor IX Complex Drug Sales Market Share by Type (2021-2032) Figure 36. Global Factor IX Complex Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Factor IX Complex Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Factor IX Complex Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Factor IX Complex Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Factor IX Complex Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Factor IX Complex Drug Sales Market Share by Application (2021-2032) Figure 42. North America Factor IX Complex Drug Revenue Share by Type (2021-2032) Figure 43. North America Factor IX Complex Drug Sales Share by Type (2021-2032) Figure 44. North America Factor IX Complex Drug Revenue Share by Application (2021-2032) Figure 45. North America Factor IX Complex Drug Sales Share by Application (2021-2032) Figure 46. North America Factor IX Complex Drug Revenue Share by Country (2021-2032) Figure 47. North America Factor IX Complex Drug Sales Share by Country (2021-2032) Figure 48. Europe Factor IX Complex Drug Revenue Share by Type (2021-2032) Figure 49. Europe Factor IX Complex Drug Sales Share by Type (2021-2032) Figure 50. Europe Factor IX Complex Drug Revenue Share by Application (2021-2032) Figure 51. Europe Factor IX Complex Drug Sales Share by Application (2021-2032) Figure 52. Europe Factor IX Complex Drug Revenue Share by Country (2021-2032) Figure 53. Europe Factor IX Complex Drug Sales Share by Country (2021-2032) Figure 54. China Factor IX Complex Drug Revenue Share by Type (2021-2032) Figure 55. China Factor IX Complex Drug Sales Share by Type (2021-2032) Figure 56. China Factor IX Complex Drug Revenue Share by Application (2021-2032) Figure 57. China Factor IX Complex Drug Sales Share by Application (2021-2032) Figure 58. Asia Factor IX Complex Drug Revenue Share by Type (2021-2032) Figure 59. Asia Factor IX Complex Drug Sales Share by Type (2021-2032) Figure 60. Asia Factor IX Complex Drug Revenue Share by Application (2021-2032) Figure 61. Asia Factor IX Complex Drug Sales Share by Application (2021-2032) Figure 62. Asia Factor IX Complex Drug Revenue Share by Country (2021-2032) Figure 63. Asia Factor IX Complex Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Factor IX Complex Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Factor IX Complex Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Factor IX Complex Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Factor IX Complex Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Factor IX Complex Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Factor IX Complex Drug Sales Share by Country (2021-2032) Figure 70. Factor IX Complex Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Factor IX Complex Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Prothromplex
  • Profilnine
  • Octaplex
  • Cofact
  • Beriplex
  • Other
Applications
  • Hemophilia B
  • Acquired Coagulation Factor Deficiency
Companies covered
  • Takeda
  • Grifols
  • Prothya Biosolutions
  • Octapharma
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Factor IX Complex Drug Market by Type
  3. 1.2.1 Global Factor IX Complex Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prothromplex
  5. 1.2.3 Profilnine
  6. 1.2.4 Octaplex
  7. 1.2.5 Cofact
  8. 1.2.6 Beriplex
  9. 1.2.7 Other
  10. 1.3 Factor IX Complex Drug Market by Application
  11. 1.3.1 Global Factor IX Complex Drug Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hemophilia B
  13. 1.3.3 Acquired Coagulation Factor Deficiency
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Factor IX Complex Drug Market Dynamics
  1. 2.1 Factor IX Complex Drug Industry Trends
  2. 2.2 Factor IX Complex Drug Industry Drivers
  3. 2.3 Factor IX Complex Drug Industry Opportunities and Challenges
  4. 2.4 Factor IX Complex Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Factor IX Complex Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Factor IX Complex Drug Revenue by Region
  3. 3.2.1 Global Factor IX Complex Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Factor IX Complex Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Factor IX Complex Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Factor IX Complex Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Factor IX Complex Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Factor IX Complex Drug Sales by Region
  9. 3.4.1 Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Factor IX Complex Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Factor IX Complex Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Factor IX Complex Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Factor IX Complex Drug Revenue by Manufacturers
  2. 4.1.1 Global Factor IX Complex Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Factor IX Complex Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Factor IX Complex Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Factor IX Complex Drug Sales by Manufacturers
  6. 4.2.1 Global Factor IX Complex Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Factor IX Complex Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Factor IX Complex Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Factor IX Complex Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Factor IX Complex Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Factor IX Complex Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Factor IX Complex Drug Manufacturers, Product Type & Application
  13. 4.7 Global Factor IX Complex Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Factor IX Complex Drug Market CR5 and HHI
  16. 4.8.2 2025 Factor IX Complex Drug Tier 1, Tier 2, and Tier 3
5 Factor IX Complex Drug Market by Type
  1. 5.1 Global Factor IX Complex Drug Revenue by Type
  2. 5.1.1 Global Factor IX Complex Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Factor IX Complex Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Factor IX Complex Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Factor IX Complex Drug Sales by Type
  6. 5.2.1 Global Factor IX Complex Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Factor IX Complex Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Factor IX Complex Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Factor IX Complex Drug Price by Type
6 Factor IX Complex Drug Market by Application
  1. 6.1 Global Factor IX Complex Drug Revenue by Application
  2. 6.1.1 Global Factor IX Complex Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Factor IX Complex Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Factor IX Complex Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Factor IX Complex Drug Sales by Application
  6. 6.2.1 Global Factor IX Complex Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Factor IX Complex Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Factor IX Complex Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Factor IX Complex Drug Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Factor IX Complex Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Factor IX Complex Drug Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Grifols
  8. 7.2.1 Grifols Company Information
  9. 7.2.2 Grifols Business Overview
  10. 7.2.3 Grifols Factor IX Complex Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Grifols Factor IX Complex Drug Product Portfolio
  12. 7.2.5 Grifols Recent Developments
  13. 7.3 Prothya Biosolutions
  14. 7.3.1 Prothya Biosolutions Company Information
  15. 7.3.2 Prothya Biosolutions Business Overview
  16. 7.3.3 Prothya Biosolutions Factor IX Complex Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Prothya Biosolutions Factor IX Complex Drug Product Portfolio
  18. 7.3.5 Prothya Biosolutions Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Factor IX Complex Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Factor IX Complex Drug Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 CSL Behring
  26. 7.5.1 CSL Behring Company Information
  27. 7.5.2 CSL Behring Business Overview
  28. 7.5.3 CSL Behring Factor IX Complex Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CSL Behring Factor IX Complex Drug Product Portfolio
  30. 7.5.5 CSL Behring Recent Developments
8 North America
  1. 8.1 North America Factor IX Complex Drug Market Size by Type
  2. 8.1.1 North America Factor IX Complex Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Factor IX Complex Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Factor IX Complex Drug Price by Type (2021-2032)
  5. 8.2 North America Factor IX Complex Drug Market Size by Application
  6. 8.2.1 North America Factor IX Complex Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Factor IX Complex Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Factor IX Complex Drug Price by Application (2021-2032)
  9. 8.3 North America Factor IX Complex Drug Market Size by Country
  10. 8.3.1 North America Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Factor IX Complex Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Factor IX Complex Drug Market Size by Type
  2. 9.1.1 Europe Factor IX Complex Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Factor IX Complex Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Factor IX Complex Drug Price by Type (2021-2032)
  5. 9.2 Europe Factor IX Complex Drug Market Size by Application
  6. 9.2.1 Europe Factor IX Complex Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Factor IX Complex Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Factor IX Complex Drug Price by Application (2021-2032)
  9. 9.3 Europe Factor IX Complex Drug Market Size by Country
  10. 9.3.1 Europe Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Factor IX Complex Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Factor IX Complex Drug Market Size by Type
  2. 10.1.1 China Factor IX Complex Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Factor IX Complex Drug Sales by Type (2021-2032)
  4. 10.1.3 China Factor IX Complex Drug Price by Type (2021-2032)
  5. 10.2 China Factor IX Complex Drug Market Size by Application
  6. 10.2.1 China Factor IX Complex Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Factor IX Complex Drug Sales by Application (2021-2032)
  8. 10.2.3 China Factor IX Complex Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Factor IX Complex Drug Market Size by Type
  2. 11.1.1 Asia Factor IX Complex Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Factor IX Complex Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Factor IX Complex Drug Price by Type (2021-2032)
  5. 11.2 Asia Factor IX Complex Drug Market Size by Application
  6. 11.2.1 Asia Factor IX Complex Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Factor IX Complex Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Factor IX Complex Drug Price by Application (2021-2032)
  9. 11.3 Asia Factor IX Complex Drug Market Size by Country
  10. 11.3.1 Asia Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Factor IX Complex Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Factor IX Complex Drug Market Size by Type
  2. 12.1.1 SAMEA Factor IX Complex Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Factor IX Complex Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Factor IX Complex Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Factor IX Complex Drug Market Size by Application
  6. 12.2.1 SAMEA Factor IX Complex Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Factor IX Complex Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Factor IX Complex Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Factor IX Complex Drug Market Size by Country
  10. 12.3.1 SAMEA Factor IX Complex Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Factor IX Complex Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Factor IX Complex Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Factor IX Complex Drug Value Chain Analysis
  2. 13.1.1 Factor IX Complex Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Factor IX Complex Drug Production Mode & Process
  6. 13.2 Factor IX Complex Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Factor IX Complex Drug Distributors
  9. 13.2.3 Factor IX Complex Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst